Quarterly report · Q1
2931.TEDINET S100TEIG
Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥46.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥302m | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥176m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥266m | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥1.4bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥111m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥216m | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥81m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥191m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥167m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥191m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | −¥168m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥71.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥59.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥63.3bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥40.3bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥39.4bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥30.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥22.5bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥18.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥1.49 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.76 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.46 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.9% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥392m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥118m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥118m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥126m |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥10.3bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥10.3bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥922m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥732m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥732m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥101m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-03-31 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-03-31 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-03-31 | ¥694m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥425m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥52m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥52m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥227m |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥10.0bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥10.0bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥572m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥758m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥758m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥95m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-03-31 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-03-31 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-03-31 | ¥249m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 455
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 10026000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 52000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 758000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10837000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 10837000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 572000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | -227000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | -95000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 249000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -425000000 | JPY |
| Operating income | Prior1YTDDuration | -176000000 | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 8286000000 | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Direct sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 8286000000 | JPY |
| Direct sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Direct sales | CurrentYTDDuration | 8286000000 | JPY |
| Distribution | CurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 853000000 | JPY |
| Distribution | CurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Distribution | CurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Distribution | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 853000000 | JPY |
| Distribution | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Distribution | CurrentYTDDuration | 853000000 | JPY |
| Original equipment manufacturing material overseas | CurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 326000000 | JPY |
| Original equipment manufacturing material overseas | CurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | CurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 326000000 | JPY |
| Original equipment manufacturing material overseas | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Original equipment manufacturing material overseas | CurrentYTDDuration | 326000000 | JPY |
| Others | CurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 836000000 | JPY |
| Others | CurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 118000000 | JPY |
| Others | CurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 732000000 | JPY |
| Others | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1686000000 | JPY |
| Others | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Others | CurrentYTDDuration | 1686000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 10303000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 118000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 732000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11154000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from contracts with customers | CurrentYTDDuration | 11154000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 10303000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 118000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 732000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 11154000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |